𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target

✍ Scribed by Christine Blancher; Adrian L. Harris


Book ID
110231193
Publisher
Springer
Year
1998
Tongue
English
Weight
547 KB
Volume
17
Category
Article
ISSN
0167-7659

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hypoxia response element-driven cytosine
✍ Laure Marignol; Ruth Foley; Thomas D. Southgate; Mary Coffey; Donal Hollywood; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract ## Background We proposed to exploit hypoxia‐inducible factor (HIF)‐1α overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF‐1α to arrangements of hypoxia response elements.

NO-sulindac inhibits the hypoxia respons
✍ Grant D. Stewart; Jyoti Nanda; David J.G. Brown; Antony C.P. Riddick; James A. R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 705 KB

## Abstract Nitric oxide‐donating non‐steroidal anti‐inflammatory drugs are safer than traditional NSAIDs and inhibit the growth of prostate cancer cells with greater potency than NSAIDs. __In vivo__, prostate cancer deposits are found in a hypoxic environment which induces resistance to chemothera

Optimizing the use of combined radioimmu
✍ Rosalyn D. Blumenthal; Alice Taylor; Lou Osorio; Rita Ochakovskaya; Jim A. Ralei 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 249 KB

Combined radioimmunotherapy (RAIT) and hypoxic cytotoxin therapy (SR4233 or NLCQ-1) have been evaluated with both modalities administered on the same day with only moderate improvement compared with the effects of RAIT alone. In a series of studies using oxygen electrodes, immunohistochemistry and r